Evidence map›Paper›PMID 35340039›Full record

ArticleHepatology (Baltimore, Md.)2022

Cellular heterogeneity and transcriptomic profiles during intrahepatic cholangiocarcinoma initiation and progression.

Tingjie Wang, Chuanrui Xu, Zhijing Zhang, Hua Wu, Xiujuan Li, Yu Zhang, Nan Deng, Ningxin Dang, Guangbo Tang, Xiaofei Yang and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Upregulation ofGenes · 2024
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Tingjie WangSchool of Automation Science and Engineering, Faculty of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Chuanrui XuSchool of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhijing ZhangSchool of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hua WuSchool of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xiujuan LiSchool of Automation Science and Engineering, Faculty of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Yu ZhangSchool of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Nan DengSchool of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ningxin DangGenome Institute, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Guangbo TangSchool of Life Science and Technology, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Xiaofei YangSchool of Computer Science and Technology, Faculty of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Bingyin ShiDepartment of Endocrinology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Zihang LiSchool of Life Science and Technology, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Lei LiSchool of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Kai YeSchool of Automation Science and Engineering, Faculty of Electronic and Information Engineering, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
First Affiliated Hospital of Xi'an Jiaotong University · CNXi'an Jiaotong University · CNUnivé (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsIntrahepatic cholangiocarcinoma (ICC) is not fully investigated, and how stromal cells contribute to ICC formation is poorly understood. We aimed to uncover ICC origin, cellular heterogeneity, and critical modulators during ICC initiation/progression, and to decipher how fibroblast and endothelial cells in the stromal compartment favor ICC progression. APPROACH AND

resultsWe performed single-cell RNA sequencing (scRNA-seq) using AKT/Notch intracellular domain-induced mouse ICC tissues at early, middle, and late stages. We analyzed the transcriptomic landscape, cellular classification and evolution, and intercellular communication during ICC initiation/progression. We confirmed the findings using quantitative real-time PCR, western blotting, immunohistochemistry or immunofluorescence, and gene knockout/knockdown analysis. We identified stress-responding and proliferating subpopulations in late-stage mouse ICC tissues and validated them using human scRNA-seq data sets. By integrating weighted correlation network analysis and protein-protein interaction through least absolute shrinkage and selection operator regression, we identified zinc finger, MIZ-type containing 1 (Zmiz1) and Y box protein 1 (Ybx1) as core transcription factors required by stress-responding and proliferating ICC cells, respectively. Knockout of either one led to the blockade of ICC initiation/progression. Using two other ICC mouse models (YAP/AKT, KRAS/p19) and human ICC scRNA-seq data sets, we confirmed the orchestrating roles of Zmiz1 and Ybx1 in ICC occurrence and development. In addition, hes family bHLH transcription factor 1, cofilin 1, and inhibitor of DNA binding 1 were identified as driver genes for ICC. Moreover, periportal liver sinusoidal endothelial cells could differentiate into tip endothelial cells to promote ICC development, and this was Dll4-Notch4-Efnb2 signaling-dependent.

conclusionsStress-responding and ICC proliferating subtypes were identified, and Zmiz1 and Ybx1 were revealed as core transcription factors in these subtypes. Fibroblast-endothelial cell interaction promotes ICC development.

Indexed as

Bile Duct NeoplasmsCholangiocarcinomaAnimalsBasic Helix-Loop-Helix ProteinsBile Ducts, IntrahepaticCell Line, TumorCofilin 1DNAEndothelial CellsHumansMiceMice, KnockoutProto-Oncogene Proteins c-aktProto-Oncogene Proteins p21(ras)TranscriptomeY-Box-Binding Protein 1Basic Helix-Loop-Helix ProteinsCofilin 1DNAProto-Oncogene Proteins c-aktProto-Oncogene Proteins p21(ras)Y-Box-Binding Protein 1

Identifiers

PMID35340039
PMCPMC9790314
OpenAlexW4220715392

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.